2013
DOI: 10.1016/j.ijpharm.2013.04.060
|View full text |Cite
|
Sign up to set email alerts
|

In vitro–in vivo evaluation of nanosuspension release from subcutaneously implantable osmotic pumps

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 41 publications
0
4
0
Order By: Relevance
“…The drug was delivered by subcutaneous implantation of an ALZET osmotic pump, with which drug delivery was expected to persist for up to 4 weeks (Hill et al, 2013). The concentration of SCH was adjusted to be approximately 0.1 mg/kg/d.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The drug was delivered by subcutaneous implantation of an ALZET osmotic pump, with which drug delivery was expected to persist for up to 4 weeks (Hill et al, 2013). The concentration of SCH was adjusted to be approximately 0.1 mg/kg/d.…”
Section: Methodsmentioning
confidence: 99%
“…SCH was administered in the subject that was at second rank in the social group, based on the observation that the increase of social rank with SCH administration was the largest in second-rank subjects in mice. The drug was delivered by subcutaneous implantation of an ALZET osmotic pump, with which drug delivery was expected to persist for up to 4 weeks ( Hill et al, 2013 ). The concentration of SCH was adjusted to be approximately 0.1 mg/kg/d.…”
Section: Methodsmentioning
confidence: 99%
“…In consideration to the barriers presented by diffusion across the RWM and Eustachian tube clearance rates, devices and modifications have been formulated to mitigate these challenges, improving ITD delivery [ 95 , 98 , 117 , 118 , 119 ]. Increasing the viscosity or mucosal adherence properties of an applied drug reduces Eustachian tube clearance, as seen in hydrogels [ 120 , 121 , 122 ].…”
Section: Local Drug Delivery Of Antioxidants To Inner Earmentioning
confidence: 99%
“…1,3,[5][6][7][8][11][12][13][26][27][28][29][30] State of the art implantable micro-devices include reservoir-based systems, controlled-release microchips, and various electrically powered microsystems. 1,2,10,31 Osmotic pumps present a convenient and reliable cost-effective drug delivery method capable of replacing repeated injections of soluble and poorly soluble drugs 32,33 for the treatment of chronically debilitating diseases. 3,4,[34][35][36] These marketed pumps use the principle of osmotic pressure for the delivery of pharmaceutical ingredients at a predetermined rate 37 and eliminate the need for frequent handling and injections, without external connectors.…”
mentioning
confidence: 99%